ENHERTU 100 MG PWD. I.V. INF. VIAL
TRASTUZUMAB DERUXTECAN
AN ANTIBODY THAT IS INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED A PRIOR ANTI-HER2-BASED REGIMEN EITHER: IN THE METASTATIC SETTING OR IN THE NEOADJUVANT OR ADJUVANT SETTING AND
